Investments
73Portfolio Exits
15Funds
1Partners & Customers
1About H.I.G. BioHealth Partners
H.I.G. BioHealth Partners invests in a broad range of life science opportunities across sectors and stages. The firm's seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. H.I.G. BioVentures invests in companies developing products for significant unmet medical needs, primarily in the following sectors: Therapeutics, Medical Devices, and Diagnostics.
H.I.G. BioHealth Partners Headquarter Location
1450 Brickell Avenue 31st Floor
Miami, Florida, 33131,
United States
305-379-2322
H.I.G. BioHealth Partners Web Traffic
H.I.G. BioHealth Partners Rank
Latest H.I.G. BioHealth Partners News
Mar 8, 2022
Previously, she worked at for Smith & Nephew’s U.S. robotics business unit where she was vice president and general manager. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it’s been delivered there. If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com. Copyright PEI Media Share with other subscribers Cancel
H.I.G. BioHealth Partners Investments
73 Investments
H.I.G. BioHealth Partners has made 73 investments. Their latest investment was in Click Therapeutics as part of their Series B on October 10, 2021.
H.I.G. BioHealth Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/22/2021 | Series B | Click Therapeutics | $52M | Yes | 15 | |
10/22/2020 | Series A - IV | Orbus Therapeutics | $10M | No | 1 | |
8/11/2020 | Series A - III | Orbus Therapeutics | $10M | No | 1 | |
7/20/2020 | Unattributed VC - II | |||||
5/26/2020 | Series A - II |
Date | 10/22/2021 | 10/22/2020 | 8/11/2020 | 7/20/2020 | 5/26/2020 |
|---|---|---|---|---|---|
Round | Series B | Series A - IV | Series A - III | Unattributed VC - II | Series A - II |
Company | Click Therapeutics | Orbus Therapeutics | Orbus Therapeutics | ||
Amount | $52M | $10M | $10M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 15 | 1 | 1 |
H.I.G. BioHealth Partners Portfolio Exits
15 Portfolio Exits
H.I.G. BioHealth Partners has 15 portfolio exits. Their latest portfolio exit was Clarus Therapeutics on September 09, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/9/2021 | Reverse Merger | 3 | |||
7/30/2021 | IPO | Public | 2 | ||
1/4/2021 | Acquired | 18 | |||
Date | 9/9/2021 | 7/30/2021 | 1/4/2021 | ||
|---|---|---|---|---|---|
Exit | Reverse Merger | IPO | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 2 | 18 |
H.I.G. BioHealth Partners Fund History
1 Fund History
H.I.G. BioHealth Partners has 1 fund, including H.I.G. BioHealth Partners III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
11/27/2019 | H.I.G. BioHealth Partners III | $128.75M | 1 |
Closing Date | 11/27/2019 |
|---|---|
Fund | H.I.G. BioHealth Partners III |
Fund Type | |
Status | |
Amount | $128.75M |
Sources | 1 |
H.I.G. BioHealth Partners Partners & Customers
1 Partners and customers
H.I.G. BioHealth Partners has 1 strategic partners and customers. H.I.G. BioHealth Partners recently partnered with Vertiflex on March 3, 2017.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
3/15/2017 | Partner | United States | HIG BioHealth invests in VertiFlex Michael Wasserman , HIG managing director , says : `` We are excited to partner with the VertiFlex management team . | 1 |
Date | 3/15/2017 |
|---|---|
Type | Partner |
Business Partner | |
Country | United States |
News Snippet | HIG BioHealth invests in VertiFlex Michael Wasserman , HIG managing director , says : `` We are excited to partner with the VertiFlex management team . |
Sources | 1 |
H.I.G. BioHealth Partners Team
2 Team Members
H.I.G. BioHealth Partners has 2 team members, including current Managing Partner, Bruce Robertson.
Name | Work History | Title | Status |
|---|---|---|---|
Bruce Robertson | Toucan Capital, GIV Venture Partners, IGEN International, and Grace | Managing Partner | Current |
Michael Wasserman | Managing Director | Current |
Name | Bruce Robertson | Michael Wasserman |
|---|---|---|
Work History | Toucan Capital, GIV Venture Partners, IGEN International, and Grace | |
Title | Managing Partner | Managing Director |
Status | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.